Wash-Free CLIA Workflow: Poclight's CRET Advantage Explained
5 min read
Understanding the Wash-Free CLIA Workflow and Its Clinical Value
Traditional chemiluminescence immunoassay (CLIA) testing has long depended on complex liquid paths, multiple washing steps, and magnetic bead separation to generate accurate results. While effective, this operational complexity contributes to longer turnaround times, higher equipment maintenance burdens, and space constraints that are particularly challenging for small clinics and decentralized health centers. Nanjing Poclight Biotechnology Co., Ltd., operating under the brand Poclight Biotechnology, has addressed these pain points by developing a wash-free CLIA workflow built on its patented Chemiluminescence Resonance Energy Transfer (CRET) technology. This approach eliminates the need for washing or separation steps entirely, offering healthcare providers a simpler, faster path to quantitative biomarker detection.
Headquartered in Nanjing, China, Poclight positions itself as an innovative R&D enterprise specializing in fifth-generation in vitro diagnostic (IVD) platforms. Its strategic focus is on solving four core industry pain points: high logistics costs tied to cold chain requirements, operational complexity in traditional CLIA systems, slow turnaround times in emergency and point-of-care settings, and space constraints in decentralized facilities.
The Technology Behind the Wash-Free Approach: CRET Platform
How Chemiluminescence Resonance Energy Transfer Works
At the core of Poclight's wash-free CLIA workflow is its proprietary CRET technology, a fifth-generation chemiluminescence platform that uses Acridine Ester and Graphene Oxide quenching. Unlike conventional magnetic bead-based assays that require multiple washing and separation cycles, CRET functions as a homogeneous immunoassay method, meaning the reaction proceeds without any wash or separation step. This design directly targets the operational complexity long associated with liquid-path-dependent CLIA systems.
According to information in Poclight's technical documentation, this no-wash, no-separation process results in a 70% reduction in time and expenditure compared to conventional workflows. The company describes CRET as a patented method authorized for IVD use, positioning it as the sole company worldwide with an authorized CRET patent for in vitro diagnostics.
Key Technical Metrics
The wash-free CLIA workflow enabled by CRET technology delivers measurable performance benchmarks:
- Test results are generated in 3 to 15 minutes, supporting rapid clinical decision-making.
- The associated instrument weighs approximately 8.5 kilograms, roughly 80% lighter than traditional analyzers.
- The device footprint is sized to fit an A4 sheet of paper, allowing it to be placed in space-limited environments.
These metrics illustrate how removing the wash step does not compromise accuracy while significantly compressing the testing timeline.
The C5000 Micro-Chemiluminescence Immunoassay Analyzer
Compact Design for Decentralized Settings
Poclight's wash-free workflow is delivered through its C5000 Micro-Chemiluminescence Immunoassay Analyzer, a compact, semi-automated benchtop device engineered for quantitative biomarker detection. The C5000 was designed specifically to address space constraints in laboratories and the need for rapid results in emergency departments. Its A4-sized footprint and roughly 8.5-kilogram weight make it suitable for small clinics, bedside use, and other decentralized clinical environments where full-scale laboratory analyzers are impractical.
Semi-Automated, Maintenance-Free Operation
The C5000 operates through a simple three-step process, reducing the operational complexity typically associated with CLIA testing. Because the wash-free CLIA workflow eliminates internal liquid paths, the analyzer requires no washing or separation hardware, resulting in a maintenance-free system with no hidden cleaning or repair costs. High sensitivity is preserved through Photon Multiplier Tube (PMT) detection, which Poclight states ensures lab-grade accuracy despite the simplified process.
The C5000 has been adapted for use across multiple clinical settings, including ICU, Emergency Departments, Cardiology, Oncology, Pediatrics, Primary Care, and Veterinary Medicine, reflecting the versatility of a wash-free approach across diverse diagnostic needs.
Room-Temperature Stable Reagents Supporting the Wash-Free Workflow
A wash-free CLIA workflow is only as effective as the reagents that support it. Poclight's diagnostic reagents are formulated as lyophilized spherical beads, a format engineered for room-temperature stability. These reagents remain stable at 2 to 30 degrees Celsius for 18 months, removing the dependency on cold chain logistics. According to Poclight, this stability translates into a 50% reduction in logistics costs, an important consideration for global shipping and remote or resource-limited clinics.
The reagent portfolio supports more than 50+ biomarkers across several clinical categories, including inflammation and infection markers such as C-Reactive Protein (CRP), Procalcitonin (PCT), and Interleukin-6 (IL-6); cardiovascular markers such as High-sensitivity Cardiac Troponin T (hs-cTnT), D-Dimer, and NT-proBNP; thyroid function tests including TSH, TT3, TT4, FT3, and FT4; fertility and hormone assays such as AMH, FSH, LH, and β-hCG; metabolic tests like HbA1c and Ferritin; tumor markers including PSA, CEA, AFP, and CA125; respiratory diagnostics such as KL-6; and platelet function testing markers including CD41, CD61, and PAC-1. This broad menu allows the wash-free workflow to serve inflammation, cardiovascular, endocrine, fertility, tumor screening, respiratory, metabolic, and platelet function testing needs from a single platform.
Broad Clinical Applications Across Diagnostic Fields
The combination of the C5000 analyzer and lyophilized reagent solutions extends the wash-free CLIA workflow into clinical medicine, primary care, gynecology, and veterinary medicine. Customer types served include medical professionals and lab directors, IVD distributors and agents, small and medium medical facilities, and veterinary hospitals and breeders. Because the system requires no cold chain and no internal liquid paths, it is particularly well suited to smaller facilities that previously lacked access to CLIA-level sensitivity.
Real-World Impact: Customer Cases
Poclight documents several scenarios illustrating the wash-free workflow in practice. In emergency chest pain centers, implementation of ultra-fast CLIA point-of-care testing has been used to reduce door-to-balloon time through rapid cardiac biomarker testing. In community health centers, the C5000 combined with lyophilized reagents has brought CLIA-level sensitivity to primary care settings without requiring large infrastructure. In ICU sepsis management, the synergy of PCT and IL-6 testing has supported rapid infection response and accelerated clinical decision-making. In decentralized women's care, benchtop CLIA integration has enabled endocrine and fertility monitoring directly within clinic settings.
Quality Certifications and Global Reach
Poclight's wash-free CLIA workflow is supported by recognized quality certifications, including CE Certification, ISO 13485 Certification, NMPA certification, and NGSP certification. The company adheres to ISO 13485 quality management standards for its data and operational practices. Poclight serves healthcare markets across South Asia, Southeast Asia, the Middle East, Africa, and Latin America, working with distributors and healthcare partners, and maintains an R&D presence through the Suzhou biopharmaceutical valley accelerator. Beyond direct equipment and reagent sales, Poclight offers OEM/ODM services, extending its wash-free CRET-based platform to partners seeking to integrate the technology into their own diagnostic offerings.
Conclusion: Why Poclight's Wash-Free CLIA Workflow Matters
For healthcare providers seeking to reduce logistics costs, simplify equipment maintenance, and deliver faster results in space-constrained or emergency settings, Poclight's wash-free CLIA workflow presents a purpose-built solution. By combining the patented CRET platform, the compact C5000 analyzer, and room-temperature stable reagents covering more than 50+ biomarkers, Poclight Biotechnology addresses core operational pain points across clinical, primary care, and veterinary diagnostic environments. As the company continues to expand its global partnership network, the wash-free CLIA workflow stands as a practical example of how simplified immunoassay design can support faster, more accessible diagnostic testing worldwide.
www.poclight.com
Nanjing Poclight Biotechnology Co., Ltd
About Author
